Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Nimble Therapeutics.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Nimble Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
500 S. Rosa Rd, Madison, WI 53719
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Nimble will apply its platform against multiple targets, and Genentech and Roche will be responsible for preclinical and clinical development, and commercialization of any resulting products.


Lead Product(s): Undisclosed

Therapeutic Area: Technology Product Name: Undisclosed

Highest Development Status: DiscoveryProduct Type: Peptide

Partner/Sponsor/Collaborator: Genentech

Deal Size: $1,120.0 million Upfront Cash: $20.0 million

Deal Type: Expanded Collaboration January 05, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Nimble has delivered lead compounds for four programs to its partners. This progress, across multiple targets and partners, validates the power of Nimble’s platform to optimize peptide therapeutics at unprecedented speed.


Lead Product(s): Undisclosed

Therapeutic Area: Technology Product Name: Undisclosed

Highest Development Status: PreclinicalProduct Type: Peptide

Partner/Sponsor/Collaborator: Undisclosed

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration December 13, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Nimble will receive payments for each milestone connected to the collaboration, and the company remains eligible for additional future downstream milestones attached to each program as development continues.


Lead Product(s): Undisclosed

Therapeutic Area: Technology Product Name: Undisclosed

Highest Development Status: DiscoveryProduct Type: Undisclosed

Partner/Sponsor/Collaborator: Undisclosed

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration May 17, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Incyte has exclusive rights to develop and commercialize any peptides discovered under the collaboration and has an option to further expand the collaboration to include additional targets.


Lead Product(s): Undisclosed

Therapeutic Area: Oncology Product Name: Undisclosed

Highest Development Status: DiscoveryProduct Type: Peptide

Partner/Sponsor/Collaborator: Incyte Corporation

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Expanded Collaboration September 14, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY